期刊文献+

人工泪液联合性激素治疗绝经后妇女干眼的临床观察 被引量:3

Observation on therapeutic efficacy of artifitial dacryma combined with hormone replacement therapy(HRT) on dry eye in post menopausal women
下载PDF
导出
摘要 目的比较两种方法治疗绝经后妇女干眼的临床效果。方法 137例绝经后干眼患者随机分为两组,观察组71例给予人工泪液治疗,对照组66例给予人工泪液联合性激素(含雌孕激素、雄激素之复合制剂)治疗,两组均定期随访6~12个月。结果自觉症状的缓解时间(半数患者),对照组31d,观察组44d,两组间差异有统计学意义;1年后基础泪液分泌试验显示有效(增加≥1mm):对照组58例(87.88%),观察组54例(76.06%);显效(增加≥3mm):对照组45例(68.18%),观察组39例(54.93%),两组间差异有统计学意义;1年后泪膜破裂时间检查显示有效(延长≥1s):对照组64例(96.97%),观察组60例(84.51%);显效(延长≥3s):对照组51例(77.27%),观察组41例(57.75%),两组间差异有统计学意义;1年后角膜荧光素钠染色评分显示有效(分值减少≥3分):对照组62例(93.94%),观察组57例(80.28%),两组间有统计学意义差异。结论人工泪液联合性激素(含雌、孕激素、雄激素之复合制剂)治疗绝经后干眼,其临床效果优于单纯用人工泪液治疗。 Objective To compare the therapeutic efficacy of two methods of treating dry eye in post menopausal women.Methods 137 post menopausal women with dry eye were devided randomly into observation group(71 cases) and control group(66 cases).Observation group accepted artifical dacryma treatment,control group accepted artifical dacryma combined with HRT.All patients followed up 6~12months posttherapy.Results There was marked difference of the time of relief of uncomfortableness(half patients) between the two groups.Follow 6 months,there were marked difference of Schirmer's test,Tear film brea-up time(BUT) and fluorescien score between the two groups.Conclusion For post menopausal female dry eye,artificial dacryma combined with HRT is better than solo artificial dacryma.
出处 《四川医学》 CAS 2011年第8期1220-1222,共3页 Sichuan Medical Journal
关键词 绝经后妇女 干眼 人工泪液 性激素 post menopausal women dry eye artificial dacryma sex hormone
  • 相关文献

参考文献6

二级参考文献29

  • 1焦凯,贾弘.核内受体超家族的结构与机能分析[J].生理科学进展,1994,25(1):27-30. 被引量:4
  • 2[1]Lange C,Fernandez J,Shim D,et al.Mucin gene expression is not regulated by estrogen and/or progesterone in the ocular surface epithelia of mice.Exp Eye Res,2003;77(1):59-68.
  • 3[2]Marcozzi G,Liberati V,Madia F,et al.Age-and genderrelated differences in human lacrimal fluid peroxidase activity.Ophthalmologica,2003;217(4):294-297.
  • 4[3]Han KO,Moon IG,Kang YS,et al.Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women.J Clin Endocrinol Metab,1997; 82(4):991-995.
  • 5[5]Beauregard C,Brandt P.Down regulation of interleukin-1 beta-induced nitric oxide production in lacrimal gland acinar cells by sex steroids.Curr Eye Res,2004;29(1):59-66.
  • 6[6]Pelit A,Bagis T,Kayaselcuk F,et al.Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women.Eur J Ophthalmol,2003; 13(4):337-342.
  • 7[7]Lang Y,Lang N,Ben-Ami M,et al.The effects of hormone replacement therapy (HRT) on the human eye.Harefuah,2002;141(3):287-291.
  • 8[8]Scott G,Yiu SC,Wasilewski D,et al.Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women.Am J Ophthalmol,2005;139(6):1109-1110.
  • 9[9]Schaumberg DA,Buring JE,Sullivan MR,et al.Hormone replacement therapy and dry eye syndrome.JAMA,2001;286(17):2114-2119.
  • 10[10]Esmaeli B,Harvey JT,Hewlett B.Immunohistochemical evidence for estrogen receptors in meibomian glands.Ophthalmology,2000;107(1):180-184.

共引文献88

同被引文献71

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部